Kovitz Investment Group Partners’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$607K Sell
7,581
-7,404
-49% -$610K 0.01% 375
2025
Q4
$1.28M Sell
14,985
-17,694
-54% -$1.45M 0.03% 286
2025
Q3
$2.54M Buy
32,679
+1,504
+5% +$118K 0.01% 594
2025
Q2
$2.44M Sell
31,175
-18,924
-38% -$1.41M 0.01% 584
2025
Q1
$3.63M Buy
50,099
+6,842
+16% +$490K 0.02% 467
2024
Q4
$3.2M Buy
43,257
+20,218
+88% +$1.42M 0.02% 487
2024
Q3
$880K Buy
23,039
+9,093
+65% +$661K 0.01% 649
2024
Q2
$1.29M Buy
13,946
+9,229
+196% +$817K 0.01% 489
2024
Q1
$451K Buy
4,717
+1,813
+62% +$152K 0.01% 523
2023
Q4
$221K Sell
2,904
-540
-16% -$37.6K ﹤0.01% 391
2023
Q3
$239K Sell
3,444
-91
-3% -$7.31K ﹤0.01% 370
2023
Q2
$333K Sell
3,535
-95
-3% -$8.26K ﹤0.01% 362
2023
Q1
$300K Buy
+3,630
New +$285K 0.01% 373
2022
Q4
Sell
-4,780
Closed -$395K 393
2022
Q3
$395K Sell
4,780
-51,628
-92% -$4.97M 0.01% 338
2022
Q2
$5.36M Buy
+56,408
New +$5.84M 0.12% 136
2021
Q4
Sell
-21,672
Closed -$2.45M 423
2021
Q3
$2.45M Sell
21,672
-129
-0.6% -$14.7K 0.05% 213
2021
Q2
$2.26M Buy
+21,801
New +$2.05M 0.04% 229

Other funds holding EW

Kovitz Investment Group Partners's EW Position: Q1 2026 in Review

Kovitz Investment Group Partners reduced its Edwards Lifesciences (EW) stake by 49% in Q1 2026, selling an estimated $610K and leaving 7,581 shares worth $607K. The position accounts for 0.01% of the portfolio, ranked #375.

Kovitz Investment Group Partners first reported a position in EW in Q2 2021 and has held it in 17 quarters since. The position peaked at $5.36M in Q2 2022. 1,287 funds tracked by Wall St. Rank hold EW as of Q1 2026.

  • Kovitz Investment Group Partners held 7,581 shares of Edwards Lifesciences worth $607K as of Q1 2026.
  • Kovitz Investment Group Partners sold 7,404 Edwards Lifesciences shares in Q1 2026, an estimated $610K.
  • Edwards Lifesciences made up 0.01% of Kovitz Investment Group Partners's portfolio in Q1 2026, its #375 holding.
  • Kovitz Investment Group Partners first reported a position in Edwards Lifesciences in Q2 2021 and has held it in 17 quarters since.
  • Kovitz Investment Group Partners's Edwards Lifesciences position peaked at $5.36M in Q2 2022.
  • 1,287 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.

Based on Kovitz Investment Group Partners's 13F filing for Q1 2026, filed 13 May 2026.